| Primary |
| Drug Use For Unknown Indication |
50.7% |
| Infection Prophylaxis |
7.9% |
| Pain |
5.7% |
| Induction Of Anaesthesia |
4.3% |
| Cellulitis |
2.9% |
| Fungal Peritonitis |
2.9% |
| Pneumonia |
2.9% |
| Postoperative Care |
2.9% |
| Upper Respiratory Tract Infection |
2.9% |
| Anaesthesia |
2.1% |
| Appendicitis |
2.1% |
| Infection |
2.1% |
| Peritonitis |
2.1% |
| Prophylaxis |
2.1% |
| Skin Laceration |
2.1% |
| Gastric Operation |
1.4% |
| Acute Respiratory Distress Syndrome |
0.7% |
| Beta Haemolytic Streptococcal Infection |
0.7% |
| Endocarditis |
0.7% |
| Granulocytopenia |
0.7% |
|
| Urticaria |
14.8% |
| Vomiting |
13.1% |
| Shock |
9.8% |
| Hot Flush |
6.6% |
| Pyrexia |
6.6% |
| Respiratory Arrest |
6.6% |
| Hepatic Function Abnormal |
4.9% |
| Rash Papular |
4.9% |
| Syncope Vasovagal |
4.9% |
| Convulsion |
3.3% |
| Tonic Convulsion |
3.3% |
| Urinary Incontinence |
3.3% |
| Vitamin K Deficiency |
3.3% |
| Wheezing |
3.3% |
| White Blood Cell Count Increased |
3.3% |
| Blood Pressure Decreased |
1.6% |
| Disseminated Intravascular Coagulation |
1.6% |
| Erythema |
1.6% |
| Flushing |
1.6% |
| Hypotonia |
1.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
21.6% |
| Hypertension |
9.4% |
| Pneumonia |
7.5% |
| Product Used For Unknown Indication |
7.5% |
| Anaesthesia |
7.2% |
| Nasopharyngitis |
4.7% |
| Pyrexia |
4.7% |
| Diabetes Mellitus |
4.1% |
| Postoperative Analgesia |
4.1% |
| Antibiotic Prophylaxis |
3.8% |
| Infection Prophylaxis |
3.4% |
| Diarrhoea |
2.8% |
| Infection |
2.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.8% |
| Thrombosis Prophylaxis |
2.8% |
| Psoas Abscess |
2.5% |
| Back Pain |
2.2% |
| Prophylaxis |
2.2% |
| Abscess |
1.9% |
| Anaesthetic Premedication |
1.9% |
|
| Tubulointerstitial Nephritis |
8.2% |
| Lung Disorder |
6.6% |
| Rash |
6.6% |
| Renal Failure Acute |
6.6% |
| Stevens-johnson Syndrome |
6.6% |
| Vomiting |
6.6% |
| Acute Generalised Exanthematous Pustulosis |
4.9% |
| Acute Respiratory Distress Syndrome |
4.9% |
| Blood Bilirubin Increased |
4.9% |
| Laryngeal Oedema |
4.9% |
| Pyrexia |
4.9% |
| Renal Impairment |
4.9% |
| Respiratory Arrest |
4.9% |
| Sepsis |
4.9% |
| Anaphylactic Shock |
3.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.3% |
| Hepatic Function Abnormal |
3.3% |
| Hyperthermia |
3.3% |
| Interstitial Lung Disease |
3.3% |
| Nephritis Interstitial |
3.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.2% |
| Prophylaxis |
13.9% |
| Hypertension |
9.2% |
| Infection Prophylaxis |
5.9% |
| Thrombosis Prophylaxis |
4.6% |
| Bursitis Infective |
4.5% |
| Colitis Ulcerative |
4.5% |
| Insomnia |
4.4% |
| Rheumatoid Arthritis |
4.1% |
| Cardiac Failure |
3.0% |
| Foetal Exposure During Pregnancy |
2.8% |
| Acute Myocardial Infarction |
2.4% |
| Pneumonia |
2.0% |
| Pulmonary Hypertension |
2.0% |
| Gastritis |
1.9% |
| Osteoporosis |
1.8% |
| Parkinson's Disease |
1.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
| Epilepsy |
1.6% |
| Pain |
1.6% |
|
| White Blood Cell Count Decreased |
11.1% |
| White Blood Cell Count Increased |
8.7% |
| Malaise |
7.1% |
| Femur Fracture |
6.3% |
| Hepatic Function Abnormal |
5.6% |
| Vomiting |
5.6% |
| Myasthenia Gravis |
4.8% |
| Paralysis |
4.8% |
| Post Procedural Haemorrhage |
4.8% |
| Verbal Abuse |
4.8% |
| Deep Vein Thrombosis |
4.0% |
| Hypoxia |
4.0% |
| Platelet Count Decreased |
4.0% |
| Pulmonary Haemorrhage |
4.0% |
| Sepsis |
4.0% |
| Toxic Epidermal Necrolysis |
4.0% |
| Febrile Neutropenia |
3.2% |
| Loss Of Consciousness |
3.2% |
| Pyrexia |
3.2% |
| Therapeutic Response Decreased |
3.2% |
|
